Home / GUFICBIO.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does GUFICBIO.NS make money? Does GUFICBIO.NS have pricing power? What's the Earnings Whisper? Will GUFICBIO.NS profit more as the business scales? What is GUFICBIO.NS's management track record? Is GUFICBIO.NS's current price justified?

Gufic Biosciences Limited

₹404.5 +$63.10 (+18.48%)

NSE · 16 Oct 2026 09:59 UTC

Previous Close

₹408.45

Day Range

₹402₹409.45

Year Range

₹268₹467.8

Market Cap

40.56B

AVG Volume

227.3K

Trailing/Forward PE

55.26/-

PEG ratio

2.96

Dividend Yield

0.02%

Next Earnings Date

Primary Exchange

National Stock Exchange of India

Revenue (INR) · A

GUFICBIO.NS Revenue (INR) by year
Period	Revenue (INR)
2026	9.44B
2025	8.2B
2024	8.13B
2023	6.91B
2022	7.79B
2021	4.51B
2020	3.58B
2019	3.42B
2018	3.01B
2017	2.46B

Net Income (INR) · A

GUFICBIO.NS Net Income (INR) by year
Period	Net Income (INR)
2026	642.14M
2025	696.49M
2024	861.36M
2023	797.05M
2022	958.4M
2021	465.17M
2020	228.57M
2019	221.83M
2018	180.55M
2017	90.21M

Operating Income (INR) · A

GUFICBIO.NS Operating Income (INR) by year
Period	Operating Income (INR)
2026	1.21B
2025	1.14B
2024	1.31B
2023	1.13B
2022	1.29B
2021	693.51M
2020	375.82M
2019	423.76M
2018	308.62M
2017	221.23M

EBITDA · A

Cash Flows · A

EPS · A

Expenses · A

Cash & Debt · A

Debt ratios · A

Margins · A

Return on Capital · A

Shares Outstanding · A

Dividends (INR) · A

Employee Count

Book Value Per Share · A

Total Assets · A

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Gufic Biosciences Limited

Video analysis: GUFICBIO.NS

News: GUFICBIO.NS

Similar companies